Brief: Lazard Asset Management's Long Position In H-Shares Of Sinopharm Group Rises To 7% - Filing
April 14 (Reuters) - Hong Kong stock exchange filing:
* LAZARD ASSET MANAGEMENT LLC'S LONG POSITION IN H-SHARES OF
SINOPHARM GROUP 1099.HK INCREASED TO 7.00% ON APRIL 6 FROM
6.97% - HKEX FILING
Source text
Further company coverage: 1099.HK
(Reporting by Hong Kong newsroom)
((twinnie.siu@tr.com; 852-3462 7715;))
Recent news on Sinopharm
See all newsBrief: Sinopharm Group Says 9M Sinopharm Accord Net Income Attributable RMB952.5 Million (Oct 20)
Medical products distributor Sinopharm Group's prelim 9-month revenue slips
Brief: BlackRock's Long Position In H Shares Of Sinopharm Reduces To 9.23% On Oct 13, HKEX Shows
Sinopharm interim revenue edges down on softness in pharmaceutical distribution business
Brief: Sinopharm Group To Sell 30.13% Stake In China National Medicines Guorui Pharmaceutical For